<DOC>
	<DOCNO>NCT02120976</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , PK single oral dos JTT-252 effect food PK JTT-252 healthy subject , evaluate safety , tolerability , PK PD single oral dos JTT-252 type 2 diabetes mellitus subject .</brief_summary>
	<brief_title>Study Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Oral Doses JTT-252</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Healthy Subject Cohorts : Healthy male female subject Age 18 50 Years ( inclusive ) Body Mass Index ( BMI ) 19.0 31.0 kg/m2 ( inclusive ) Type 2 Diabetic Subject Cohorts : Male female Type 2 diabetic subject currently treat stable dose metformin Age 18 65 Years ( inclusive ) BMI 25.0 40.0 kg/m2 ( inclusive ) Have glycosylated hemoglobin ( HbA1c ) &gt; 7.0 % â‰¤9.5 % Have fast plasma glucose ( FPG ) &lt; 240 mg/dL Healthy Subject Cohorts : Known clinically relevant history presence significant respiratory , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , metabolic dermatological connective tissue disease Subjects systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg Type 2 Diabetic Subject Cohorts : Subjects know medical history presence type 1 diabetes mellitus Subjects know medical history acute metabolic diabetic complication Subjects uncontrolled hypertension ( systolic blood pressure &gt; 150 mmHg and/or diastolic blood pressure &gt; 95 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Food-effect</keyword>
	<keyword>Diabetes</keyword>
</DOC>